Thrombosis Research
Volume 125, Issue 6 , Pages 533-537 , June 2010

Mutant Macaque Factor IX T262A: A Tool for Hemophilia B Gene Therapy Studies in Macaques

  • Akira Ishiwata

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • These authors contributed equally to this work.
    • ,
  • Jun Mimuro

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • Hematology Division of Department of Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • These authors contributed equally to this work.
    • Corresponding Author InformationCorresponding authors. Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan. Tel.: +81 285 58 7398; fax: +81 285 44 7817.
    • ,
  • Hiroaki Mizukami

      Affiliations

    • Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Yuji Kashiwakura

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Atsushi Yasumoto

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Asuka Sakata

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Tsukasa Ohmori

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • Hematology Division of Department of Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Seiji Madoiwa

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • Hematology Division of Department of Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Fumiko Ono

      Affiliations

    • The Corporation for Production and Research of Laboratory Primates, Tsukuba, Ibaraki-ken 305-0843, Japan
    • Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Tsukuba, Ibaraki-ken 305-0843, Japan
    • ,
  • Midori Shima

      Affiliations

    • Department of Pediatrics, Nara Medical University, Kashihara, Nara-ken 634-8522, Japan
    • ,
  • Akira Yoshioka

      Affiliations

    • Department of Pediatrics, Nara Medical University, Kashihara, Nara-ken 634-8522, Japan
    • ,
  • Keiya Ozawa

      Affiliations

    • Hematology Division of Department of Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • ,
  • Yoichi Sakata

      Affiliations

    • Divisions of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • Hematology Division of Department of Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan
    • Corresponding Author InformationCorresponding authors. Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi-ken 329-0498, Japan. Tel.: +81 285 58 7398; fax: +81 285 44 7817.

Received 9 November 2009 ,Revised 12 January 2010 ,Accepted 25 January 2010.

References 

  1. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33–40
  2. Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: are we there yet?. J Clin Invest. 2007;117:1456–1465
  3. Hasbrouck NC, High KA. AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects. Gene Ther. 2008;15:870–875
  4. Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annu Rev Biochem. 2005;74:711–738
  5. Cavazzana-Calvo M, Hacein-Bey S. de Saint Basile G, Gross F, Yvon E, Nusbaum P, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669–672
  6. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 2002;296:2410–2413
  7. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002;346:1185–1193
  8. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–419
  9. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12:342–347
  10. Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 2003;101:2963–2972
  11. Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN, et al. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood. 2006;107:2653–2661
  12. Hoffman BE, Dobrzynski E, Wang L, Hirao L, Mingozzi F, Cao O, et al. Muscle as a target for supplementary factor IX gene transfer. Hum Gene Ther. 2007;18:603–613
  13. Lu Y. Recombinant adeno-associated virus as delivery vector for gene therapy–a review. Stem Cells Dev. 2004;13:133–145
  14. Nathwani AC, Davidoff AM, Hanawa H, Hu Y, Hoffer FA, Nikanorov A, et al. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood. 2002;100:1662–1669
  15. Nathwani AC, Gray JT, McIntosh J, Ng CY, Zhou J, Spence Y, et al. Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood. 2007;109:1414–1421
  16. Lozier JN, Metzger ME, Donahue RE, Morgan RA. The rhesus macaque as an animal model for hemophilia B gene therapy. Blood. 1999;93:1875–1881
  17. Lozier JN, Metzger ME, Donahue RE, Morgan RA. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood. 1999;94:3968–3975
  18. Mimuro J, Mizukami H, Ono F, Madoiwa S, Terao K, Yoshioka A, et al. Specific detection of human coagulation factor IX in cynomolgus macaques. J Thromb Haemost. 2004;2:275–280
  19. Tomokiyo K, Teshima K, Nakatomi Y, Watanabe T, Mizuguchi J, Nozaki C, et al. Induction of acquired factor IX inhibitors in cynomolgus monkey (Macaca fascicularis): a new primate model of hemophilia B. Thromb Res. 2001;102:363–374
  20. Allan CM, Taylor S, Taylor JM. Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster. J Biol Chem. 1997;272:29113–29119
  21. Simonet WS, Bucay N, Lauer SJ, Taylor JM. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem. 1993;268:8221–8229
  22. Dang Q, Walker D, Taylor S, Allan C, Chin P, Fan J, et al. Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus. J Biol Chem. 1995;270:22577–22585
  23. Miao CH, Ohashi K, Patijn GA, Meuse L, Ye X, Thompson AR, et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther. 2000;1:522–532
  24. Ishiwata A, Mimuro J, Mizukami H, Kashiwakura Y, Takano K, Ohmori T, et al. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice. J Gene Med. 2009;11:1020–1029
  25. Ishiwata A, Mimuro J, Kashiwakura Y, Niimura M, Takano K, Ohmori T, et al. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene. Thromb Res. 2006;118:627–635
  26. Muramatsu S, Fujimoto K, Ikeguchi K, Shizuma N, Kawasaki K, Ono F, et al. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes. Hum Gene Ther. 2002;13:345–354

PII: S0049-3848(10)00104-0

doi: 10.1016/j.thromres.2010.01.049

Thrombosis Research
Volume 125, Issue 6 , Pages 533-537 , June 2010

Article Tools

* Image Usage & Resolution